Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230541 · ClinicalTrials.gov registry record · Phase 1
Effect of Udenafil on Spermatogenesis
A Phase 1 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 1
- Development phase
- 239
- Enrollment target
NCT01230541 is a Phase 1 study that has completed, run by Warner Chilcott. The registered enrollment target is 239 participants.
The verdict
NCT01230541, a Phase 1 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 239 participants
- Enrollment target
Study Summary
Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
Interventions
- DRUG Placebo
- DRUG Udenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01230541
The ClinicalTrials.gov registry entry for NCT01230541 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01230541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01230541 about?
NCT01230541 is a clinical study titled "Effect of Udenafil on Spermatogenesis". Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
What is the current status of trial NCT01230541?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 239 participants. The study started on 2010-09. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01230541?
The interventions under investigation include: Placebo (DRUG), Udenafil (DRUG).
Who is sponsoring clinical trial NCT01230541?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.